- Home
- ECOR vs OPRX Comparison
ECOR vs OPRX Comparison
Compare ECOR & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ECOR | OPRX |
|---|---|---|
| Founded | 2005 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.0M | 117.1M |
| IPO Year | 2018 | 2008 |
Fundamental Metrics
Financial Performance| Metric | ECOR | OPRX |
|---|---|---|
| Price | $6.05 | $6.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $18.00 | $16.67 |
| AVG Volume (30 Days) | 80.2K | ★ 301.7K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 124.55 |
| EPS | N/A | ★ N/A |
| Revenue | $32,032,000.00 | ★ $109,429,000.00 |
| Revenue This Year | $33.60 | $3.88 |
| Revenue Next Year | $30.40 | $8.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 27.20 | 18.78 |
| 52 Week Low | $4.16 | $4.54 |
| 52 Week High | $10.50 | $22.25 |
Technical Indicators
Market Signals| Indicator | ECOR | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 38.55 | 56.91 |
| Support Level | $5.69 | $6.03 |
| Resistance Level | $7.35 | $6.93 |
| Average True Range (ATR) | 0.66 | 0.24 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 20.48 | 48.47 |
Price Performance
Historical ComparisonAbout ECOR electroCore Inc.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.